Japan's Asahi Kasei to buy Danish pharma Veloxis for $1.3b

Hideki Kobori, president of Asahi Kasei Corp., poses for a photograph in Tokyo, Japan, on Friday, Dec. 8, 2017. Photographer: Akio Kon/Bloomber

Asahi Kasei Corp. is buying Denmark’s Veloxis Pharmaceuticals A/S for 143.2 billion yen ($1.3 billion), the companies said, in the latest of a series of deals by Japanese drugmakers.

Asahi Kasei is offering to buy the ordinary shares and warrants of Veloxis for 6 kroner per share in a tender starting next month, they said in a statement Monday. That’s a discount to the 6.6 kroner closing price on Friday, before the news was announced. In Monday’s early trading, the stock fell by about 9% to the offer price of 6 kroner.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter